Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Syntimmune
is defunct.
Acquired by Alexion, Nov 2018, $400M + $800M milestones
------------------
If you believe any of this information is incorrect, please
let us know
.